[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
Publication Charge
►Publication Fee
In Press
 In Press Articles
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 6, Issue 2 (4-2015) ::
Caspian J Intern Med 2015, 6(2): 103-107 Back to browse issues page
Immunohistochemical expression of CD10 in cutaneous basal and squamous cell carcinomas
Shahryar Shafaei , Mahnaz Sharifian , Karimolah Hajian
Department of Pathology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran , drsharif_m@yahoo.com
Abstract:   (7858 Views)

 Background: Non-melanoma skin cancer is the most common malignant tumor in humans. The role of ultraviolet radiation is well-known in the pathogenesis of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). CD10 is a zinc-dependent metallopeptidase known as common acute lymphoblastic leukemia antigen (CALLA). Although CD10 expression has been investigated in some cutaneous tumors, to our knowledge, data regarding its expression in cutaneous epithelial neoplasms are very limited. In this study, we aimed to determine the immunohistochemical expression of CD10 in BCC and SCC and to find whether it could distinguish between these two skin malignancies. 

Methods: Twenty SCC and 42 BCC cases were retrieved randomly from Ayatollah Rouhani Hospital pathology archive and CD10 expression was determined in tumoral and stromal cells of each case based on immunohistochemical method. Positive CD10 staining was identified as brown cytoplasmic, with or without cell membrane staining.

 Results: In all the 20 SCC cases, tumor cells failed to stain with CD10 in contrast to the stromal cells that showed CD10 expression in 18 cases (90%). In BCC cases, the expression of CD10 was noted in tumor cells in 25 cases (59.5%) and in stromal cells of 32 cases (76.2%). There was no relation between CD10 expression in aggressive and non- aggressive BCC. 

Conclusion: Our findings suggest that CD10 is a useful immunohistochemical marker to differentiate between BCC and SCC. At least, if tumor cells were CD10 positive, this would favor BCC over SCC. Due to small number of aggressive BCC in contrast to non- aggressive types, more studies need to be done to prove or rule out this finding.  

Keywords: CD 10, Immunostaining, BCC, SCC
Full-Text [PDF 292 kb]   (2238 Downloads)    
Type of Study: Original Article | Subject: Infectious Diseases
Received: 2014/01/10 | Accepted: 2014/12/16 | Published: 2015/03/17
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

shafaei S, sharifian M, hajian K. Immunohistochemical expression of CD10 in cutaneous basal and squamous cell carcinomas. Caspian J Intern Med 2015; 6 (2) :103-107
URL: http://caspjim.com/article-1-56-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 2 (4-2015) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 40 queries by YEKTAWEB 4639